Your browser doesn't support javascript.
loading
Enhancing durability of CIS43 monoclonal antibody by Fc mutation or AAV delivery for malaria prevention.
Kisalu, Neville K; Pereira, Lais D; Ernste, Keenan; Flores-Garcia, Yevel; Idris, Azza H; Asokan, Mangaiarkarasi; Dillon, Marlon; MacDonald, Scott; Shi, Wei; Chen, Xuejun; Pegu, Amarendra; Schön, Arne; Zavala, Fidel; Balazs, Alejandro B; Francica, Joseph R; Seder, Robert A.
Affiliation
  • Kisalu NK; Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, Maryland, USA.
  • Pereira LD; Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, Maryland, USA.
  • Ernste K; Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, Maryland, USA.
  • Flores-Garcia Y; Malaria Research Institute, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Idris AH; Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, Maryland, USA.
  • Asokan M; Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, Maryland, USA.
  • Dillon M; Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, Maryland, USA.
  • MacDonald S; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts, USA.
  • Shi W; Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, Maryland, USA.
  • Chen X; Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, Maryland, USA.
  • Pegu A; Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, Maryland, USA.
  • Schön A; Department of Biology, Johns Hopkins University, Baltimore, Maryland, USA.
  • Zavala F; Malaria Research Institute, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Balazs AB; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts, USA.
  • Francica JR; Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, Maryland, USA.
  • Seder RA; Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, Maryland, USA.
JCI Insight ; 6(3)2021 02 08.
Article in En | MEDLINE | ID: mdl-33332286
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Plasmodium falciparum / Malaria, Falciparum / Antibodies, Monoclonal Limits: Animals / Female / Humans Language: En Year: 2021 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Plasmodium falciparum / Malaria, Falciparum / Antibodies, Monoclonal Limits: Animals / Female / Humans Language: En Year: 2021 Type: Article